Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, Australia.
Ophthalmology. 2013 Oct;120(10):2091-9. doi: 10.1016/j.ophtha.2013.03.032. Epub 2013 May 30.
To describe the change in visual acuity (VA) and incidence of visual impairment (VI) in an older population over a 15-year period.
Population-based cohort.
Of the 3654 participants of the Blue Mountains Eye Study (BMES) baseline examination from 1992 through 1994, 1149 were re-examined during the 15-year follow-up between 2007 and 2010.
Best-corrected VA by means of subjective refraction was measured with a logarithm of the minimum angle of resolution chart using Early Treatment Diabetic Retinopathy Study methods at each examination.
Unilateral VI was defined as VA worse than 20/40 and blindness was defined as VA worse than 20/200 in the worse eye. Incident bilateral VI and blindness were determined according to VA in the better eye at the 15-year visit. Doubling of the visual angle was defined as a loss of 15 letters or more from baseline to the 15-year visit. Halving of the visual angle was defined as a VA improvement of 15 letters or more over the same period. Causes of VI were determined at examination, by photographic grading, and from medical records.
Cumulative 15-year incidence of unilateral and bilateral VI was 12.3% (95% confidence interval [CI], 11.0-13.6) and 5.2% (95% CI, 4.3-6.1), respectively, and for unilateral and bilateral blindness, the cumulative incidence was 3.7% (95% CI, 3.0-4.4) and 0.9% (95% CI, 0.5-1.3), respectively. These incidence rates increased significantly with increasing age (P<0.01 for trend). Doubling and halving of the visual angle occurred in 6.9% (95% CI, 5.9-7.9) and 1.6% (95% CI, 1.0-2.2) of participants, respectively. Cataract accounted for 48.5% of unilateral and bilateral incident VI, followed by age-related macular degeneration (26.9%). Age-related macular degeneration accounted for 56.9% of unilateral and bilateral incident blindness cases, followed by cataract (20.7%).
These data provide population-based estimates of long-term incidence of visual impairment among older persons. Our estimate for cumulative incidence of blindness, accounting for competing risk of death, was similar to that of the Beaver Dam Eye Study (BDES) after age standardization. However, our estimate for cumulative incidence of VI was lower compared with that observed in the BDES population. This difference may be explained in part by a higher mortality rate among our population.
FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
描述在 15 年内,老年人群体的视力(VA)变化和视力障碍(VI)的发生率。
基于人群的队列研究。
1992 年至 1994 年参加蓝山眼部研究(BMES)基线检查的 3654 名参与者中,有 1149 名在 2007 年至 2010 年的 15 年随访期间接受了复查。
使用早期糖尿病视网膜病变研究方法,通过主观折射,使用最小角度分辨率图表测量最佳矫正视力(VA),并在每次检查中进行测量。
单侧 VI 定义为 VA 差于 20/40,而双眼 VI 定义为差于 20/200 的视力较差眼的失明。根据 15 年访视时较好眼的 VA,确定双侧 VI 和失明的新发情况。视角倍增定义为从基线到 15 年访视时损失 15 个字母或更多。视角减半定义为同一时期 VA 改善 15 个字母或更多。通过检查、照相分级和病历确定 VI 的原因。
单侧和双侧 VI 的 15 年累积发生率分别为 12.3%(95%置信区间[CI],11.0-13.6)和 5.2%(95% CI,4.3-6.1),单侧和双侧失明的累积发生率分别为 3.7%(95% CI,3.0-4.4)和 0.9%(95% CI,0.5-1.3)。这些发病率随着年龄的增长显著增加(趋势 P<0.01)。6.9%(95% CI,5.9-7.9)和 1.6%(95% CI,1.0-2.2)的参与者分别出现视角倍增和减半。白内障占单侧和双侧新发 VI 的 48.5%,其次是年龄相关性黄斑变性(26.9%)。年龄相关性黄斑变性占单侧和双侧新发失明病例的 56.9%,其次是白内障(20.7%)。
这些数据提供了老年人长期视力障碍发生率的基于人群的估计。我们对考虑死亡竞争风险的失明累积发生率的估计与年龄标准化后的比佛坝眼研究(BDES)相似。然而,与 BDES 人群观察到的相比,我们对 VI 累积发生率的估计较低。这种差异部分可能是由于我们的人群死亡率较高。
作者在本文讨论的任何材料中均没有任何专有的或商业的利益。